Expression and extracellular release of a functional anti-trypanosome Nanobody ® in Sodalis glossinidius, a bacterial symbiont of the tsetse fly

Microbial Cell Factories

Volumn 11, Issue , 2012, Pages

  De Vooght, Linda ^a   Caljon, Guy ^a,b,c   Stijlemans, Benoît ^b,c   De Baetselier, Patrick ^b,c   Coosemans, Marc ^a   Van Den Abbeele, Jan ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Expression; Functional; Glossina; Nanobody; Paratransgenesis; Sodalis glossinidius; Symbiont

Indexed keywords

BACTERIUM ANTIBODY; EPITOPE; NANOBODY; UNCLASSIFIED DRUG; VARIANT SURFACE GLYCOPROTEIN; GLYCOPROTEIN; HYBRID PROTEIN; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY; SIGNAL PEPTIDE;

ARTICLE; BACTERIAL STRAIN; CYTOPLASM; ENDOSYMBIONT; IN VITRO STUDY; NONHUMAN; SODALIS GLOSSINIDIUS; SYMBIONT; TRYPANOSOMA BRUCEI; TSETSE FLY; ANIMAL; BIOSYNTHESIS; ENTEROBACTERIACEAE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; SYMBIOSIS;

BACTERIA (MICROORGANISMS); GLOSSINA (GENUS); NEGIBACTERIA; SODALIS; SODALIS GLOSSINIDIUS; TRYPANOSOMA BRUCEI;

ANIMALS; ANTIBODIES, PROTOZOAN; ENTEROBACTERIACEAE; GENE EXPRESSION; GLYCOPROTEINS; PERIPLASM; PROTEIN SORTING SIGNALS; PROTOZOAN PROTEINS; RECOMBINANT FUSION PROTEINS; SYMBIOSIS; TRYPANOSOMA BRUCEI BRUCEI; TSETSE FLIES;

EID: 84857016910     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-11-23     Document Type: Article

References (39)

1. Cheng Q, Aksoy S. Tissue tropism, transmission and expression of foreign genes in vivo in midgut symbionts of tsetse flies. Insect Mol Biol 1999, 8:125-132. 10.1046/j.1365-2583.1999.810125.x, 9927181.
2. Beard CB, O'Neill SL, Mason P, Mandelco L, Woese CR, Tesh RB, et al. Genetic transformation and phylogeny of bacterial symbionts from tsetse. Insect Mol Biol 1993, 1:123-131. 10.1111/j.1365-2583.1993.tb00113.x, 8269090.
3. Welburn SC, Maudlin I, Ellis DS. In vitro cultivation of rickettsia-like-organisms from Glossina spp. Ann Trop Med Parasitol 1987, 81:331-335.
4. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001, 292:1115-1118. 10.1126/science.1058709, 11352068.
5. Aksoy S, Weiss BL, Attardo G. Transgenesis and the management of vector-borne diseases. Paratransgenesis applied for control of tsetse transmitted sleeping sickness 2008, 35-45. Landes Bioscience: Texas, Aksoy S.
6. Durvasula RV, Gumbs A, Panackal A, Kruglov O, Aksoy S, Merrifield RB, et al. Prevention of insect-borne disease: an approach using transgenic symbiotic bacteria. Proc Natl Acad Sci USA 1997, 94:3274-3278. 10.1073/pnas.94.7.3274, 20359, 9096383.
7. Bisi DC, Lampe DJ. Secretion of anti-Plasmodium effector proteins from a natural Pantoea agglomerans isolate by using PelB and HlyA secretion signals. Appl Environ Microbiol 2011, 77:4669-4675. 10.1128/AEM.00514-11, 3127683, 21602368.
8. Hao Z, Kasumba I, Lehane MJ, Gibson WC, Kwon J, Aksoy S. Tsetse immune responses and trypanosome transmission: implications for the development of tsetse-based strategies to reduce trypanosomiasis. Proc Natl Acad Sci USA 2001, 98:12648-12653. 10.1073/pnas.221363798, 60108, 11592981.
9. Boulanger N, Brun R, Ehret-Sabatier L, Kunz C, Bulet P. Immunopeptides in the defense reactions of Glossina morsitans to bacterial and Trypanosoma brucei brucei infections. Insect Biochem Mol Biol 2002, 32:369-375. 10.1016/S0965-1748(02)00029-2, 11886771.
10. Hao Z, Kasumba I, Aksoy S. Proventriculus (cardia) plays a crucial role in immunity in tsetse fly (Diptera: Glossinidiae). Insect Biochem Mol Biol 2003, 33:1155-1164. 10.1016/j.ibmb.2003.07.001, 14563366.
11. Hu Y, Aksoy S. An antimicrobial peptide with trypanocidal activity characterized from Glossina morsitans morsitans. Insect Biochem Mol Biol 2005, 35:105-115. 10.1016/j.ibmb.2004.10.007, 15681221.
12. Haines LR, Hancock RE, Pearson TW. Cationic antimicrobial peptide killing of African trypanosomes and Sodalis glossinidius, a bacterial symbiont of the insect vector of sleeping sickness. Vector Borne Zoonotic Dis 2003, 3:175-186. 10.1089/153036603322662165, 14733670.
13. Durvasula RV, Gumbs A, Panackal A, Kruglov O, Taneja J, Kang AS, et al. Expression of a functional antibody fragment in the gut of Rhodnius prolixus via transgenic bacterial symbiont Rhodococcus rhodnii. Med Vet Entomol 1999, 13:115-119. 10.1046/j.1365-2915.1999.00175.x, 10484156.
14. Glockshuber R, Malia M, Pfitzinger I, Pluckthun A. A comparison of strategies to stabilize immunoglobulin Fv-fragments. Biochemistry 1990, 29:1362-1367. 10.1021/bi00458a002, 2110478.
15. Whitlow M, Bell BA, Feng SL, Filpula D, Hardman KD, Hubert SL, et al. An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability. Protein Eng 1993, 6:989-995. 10.1093/protein/6.8.989, 8309948.
16. Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, et al. Naturally occurring antibodies devoid of light chains. Nature 1993, 363:446-448. 10.1038/363446a0, 8502296.
17. Muyldermans S. Single domain camel antibodies: current status. J Biotechnol 2001, 74:277-302.
18. Flajnik MF, Deschacht N, Muyldermans S. A case of convergence: why did a simple alternative to canonical antibodies arise in sharks and camels?. PLoS Biol 2011, 9:e1001120. 10.1371/journal.pbio.1001120, 3149040, 21829328.
19. Van Bockstaele F, Holz JB, Revets H. The development of nanobodies for therapeutic applications. Curr Opin Investig Drugs 2009, 10:1212-1224.
20. Cortez-Retamozo V, Backmann N, Senter PD, Wernery U, De BP, Muyldermans S, et al. Efficient cancer therapy with a nanobody-based conjugate. Cancer Res 2004, 64:2853-2857. 10.1158/0008-5472.CAN-03-3935, 15087403.
21. Saerens D, Stijlemans B, Baral TN, Nguyen Thi GT, Wernery U, Magez S, et al. Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens. J Immunol Methods 2008, 329:138-150. 10.1016/j.jim.2007.10.005, 17996887.
22. Dumoulin M, Conrath K, Van MA, Meersman F, Heremans K, Frenken LG, et al. Single-domain antibody fragments with high conformational stability. Protein Sci 2002, 11:500-515. 2373476, 11847273.
23. Arbabi GM, Desmyter A, Wyns L, Hamers R, Muyldermans S. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett 1997, 414:521-526. 10.1016/S0014-5793(97)01062-4, 9323027.
24. Stijlemans B, Conrath K, Cortez-Retamozo V, Van XH, Wyns L, Senter P, et al. Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J Biol Chem 2004, 279:1256-1261.
25. Minamino T, Namba K. Self-assembly and type III protein export of the bacterial flagellum. J Mol Microbiol Biotechnol 2004, 7:5-17. 10.1159/000077865, 15170399.
26. Majander K, Anton L, Antikainen J, Lang H, Brummer M, Korhonen TK, et al. Extracellular secretion of polypeptides using a modified Escherichia coli flagellar secretion apparatus. Nat Biotechnol 2005, 23:475-481. 10.1038/nbt1077, 15806100.
27. Pontes MH, Babst M, Lochhead R, Oakeson K, Smith K, Dale C. Quorum sensing primes the oxidative stress response in the insect endosymbiont Sodalis glossinidius. PLoS One 2008, 3:3541.
28. Georgiou G, Segatori L. Preparative expression of secreted proteins in bacteria: status report and future prospects. Curr Opin Biotechnol 2005, 16:538-545. 10.1016/j.copbio.2005.07.008, 16095898.
29. Sandkvist M, Bagdasarian M. Secretion of recombinant proteins by Gram-negative bacteria. Curr Opin Biotechnol 1996, 7:505-511. 10.1016/S0958-1669(96)80053-X, 8939628.
30. Jonasson P, Liljeqvist S, Nygren PA, Stahl S. Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli. Biotechnol Appl Biochem 2002, 35:91-105. 10.1042/BA20010099, 11916451.
31. Choi JH, Lee SY. Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl Microbiol Biotechnol 2004, 64:625-635. 10.1007/s00253-004-1559-9, 14966662.
32. De Vooght L, Caljon G, Coosemans M, Van den Abbeele J. Functional analysis of the twin-arginine translocation pathway in Sodalis glossinidius, a bacterial symbiont of the tsetse fly. Appl Environ Microbiol 2011, 77:1132-1134. 10.1128/AEM.02379-10, 3028725, 21148698.
33. Harmsen MM, Van Solt CB, Van Zijderveld-Van Bemmel AM, Niewold TA, Van Zijderveld FG. Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy. Appl Microbiol Biotechnol 2006, 72:544-551. 10.1007/s00253-005-0300-7, 16450109.
34. Stijlemans B, Caljon G, Natesan SK, Saerens D, Conrath K, Perez-Morga D, et al. High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis. PLoS Pathog 2011, 7:e1002072. 10.1371/journal.ppat.1002072, 3116811, 21698216.
35. Marx CJ, Lidstrom ME. Development of improved versatile broad-host-range vectors for use in methylotrophs and other Gram-negative bacteria. Microbiology 2001, 147:2065-2075.
36. Skerra A, Pluckthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 1988, 240:1038-1041. 10.1126/science.3285470, 3285470.
37. Caljon G, Caveliers V, Lahoutte T, Stijlemans B, Ghassabeh GH, Van Den Abbeele J, et al. Analysis of blood-brain barrier permeability of monovalent Nanobodies using microdialysis. Br J Pharmacol 2012, doi: 10.1111/j.1476-5381.2011.01723.x.
38. Buscher P, Mumba ND, Kabore J, Lejon V, Robays J, Jamonneau V, et al. Improved Models of Mini Anion Exchange Centrifugation Technique (mAECT) and Modified Single Centrifugation (MSC) for sleeping sickness diagnosis and staging. PLoS Negl Trop Dis 2009, 3:e471. 10.1371/journal.pntd.0000471, 2775158, 19936296.
39. Van RN, Pyana PP, Deborggraeve S, Buscher P, Claes F. Trypanosoma brucei gambiense: HMI-9 medium containing methylcellulose and human serum supports the continuous axenic in vitro propagation of the bloodstream form. Exp Parasitol 2011, 128:285-290. 10.1016/j.exppara.2011.02.018, 21354143.